U.S. Other Utilities Stock News

NYSE:LUV
NYSE:LUVAirlines

The Bull Case For Southwest Airlines (LUV) Could Change Following Spirit Rescue Fares And Legal Payout

In late April 2026, Southwest Airlines began offering discounted fares and A-List status matches to travelers stranded by Spirit Airlines’ shutdown, while also concluding a long-running legal dispute by paying US$946,102.87 in damages to former flight attendant Charlene Carter. This combination of opportunistic customer outreach to Spirit passengers and the resolution of a nearly decade-long legal case could influence how investors weigh Southwest’s growth opportunities against its legal and...
NYSE:MGM
NYSE:MGMHospitality

Is MGM Resorts (MGM) Attractive After A 20.7% Year Gain And Recent Pullback?

Wondering if MGM Resorts International at around US$37.91 is a bargain or already pricing in the story? This article walks through what the current valuation signals might mean for you. The stock is up 20.7% over the last year, with returns of 3.9% year to date and 3.4% over the last month. However, the most recent week saw a 4.6% decline. Recent headlines around MGM Resorts International have focused on the company as a key player in US leisure and entertainment, with investors weighing how...
NasdaqGS:UPST
NasdaqGS:UPSTConsumer Finance

Is It Time To Reconsider Upstart Holdings (UPST) After Recent Share Price Swings?

If you are wondering whether Upstart Holdings at around US$31.17 is priced for a comeback or still carrying too much risk, the starting point is to understand what the current market value really reflects. The stock has been volatile, with a 5.1% decline over the last 7 days, a 21.9% gain over the last 30 days, a 32.0% decline year to date, and a 39.4% decline over the last year. The 3-year return sits at 121.2%, and the 5-year return at a 65.1% decline. Recent coverage around Upstart often...
NasdaqGS:CYTK
NasdaqGS:CYTKBiotechs

Assessing Cytokinetics (CYTK) Valuation After Recent Share Price Momentum

Why Cytokinetics Stock Is Back on Investors’ Radar Cytokinetics (CYTK) has climbed recently, with the stock up 16.7% over the past day and 27% over the past week, prompting investors to reassess what is currently priced into this biopharmaceutical story. See our latest analysis for Cytokinetics. Today’s share price of $77.09 sits against a 1-year total shareholder return of 126.9% and a 5-year total shareholder return of about 3.2x. Recent double digit share price gains suggest momentum has...
NYSE:TDAY
NYSE:TDAYMedia

The Bull Case For USA TODAY (TDAY) Could Change Following Q1 Profit Rebound On Digital And AI Deals

In the first quarter of 2026, USA TODAY Co., Inc. reported revenue of US$548.49 million, down from US$571.57 million a year earlier, while turning a prior net loss of US$7.33 million into net income of US$19.89 million. The company credited improved profitability to growing digital revenue, AI-related licensing deals, and subscription gains, and reiterated full-year 2026 guidance calling for flat to slightly lower revenue but higher net income compared with last year. Next, we will examine...
NasdaqGS:CNOB
NasdaqGS:CNOBBanks

A Look At ConnectOne Bancorp (CNOB) Valuation After Strong Q1 Earnings And Dividend Increase

Q1 earnings and dividend move draw fresh attention to ConnectOne Bancorp stock ConnectOne Bancorp (CNOB) just reported first quarter results with higher net interest income, net income and earnings per share versus a year ago, alongside an 8.3% increase in its quarterly common dividend. See our latest analysis for ConnectOne Bancorp. At a share price of $30.08, ConnectOne Bancorp has a 30 day share price return of 11.28% and a year to date share price return of 15.16%, alongside a 1 year...
NasdaqGM:NTLA
NasdaqGM:NTLABiotechs

ARK Invest’s NTLA Buy Puts Dilution And CRISPR Progress In Focus

ARK Invest recently acquired over 3 million Intellia Therapeutics shares, worth more than US$43 million. The purchase reflects increased institutional interest in Intellia Therapeutics, which trades under ticker NasdaqGM:NTLA. This transaction follows earlier coverage that focused on Intellia's clinical programs, regulatory updates, and financial position. Intellia Therapeutics focuses on CRISPR/Cas9-based therapeutics, an area that many investors watch closely as gene editing moves from...
NYSE:MKL
NYSE:MKLInsurance

A Look At Markel Group (MKL) Valuation As Shares Trade Below Narrative Fair Value

Markel Group stock performance snapshot Markel Group (MKL) has seen mixed recent trading, with the stock up roughly 0.8% over the past day but showing declines over the past week, month, past 3 months and year to date. Over the past year, Markel Group reports revenue of US$16.0b and net income of US$1.7b, with its diversified operations spanning specialty insurance, industrial businesses, financial services and various consumer focused subsidiaries. See our latest analysis for Markel...
NasdaqCM:SLNO
NasdaqCM:SLNOBiotechs

A Look At Soleno Therapeutics (SLNO) Valuation After Recent Share Momentum And VYKAT XR Launch Progress

Soleno Therapeutics stock overview Soleno Therapeutics (SLNO) has drawn investor attention after recent share performance, with the stock showing a one-month return of 34.01% and a three-month return of 25.64%. See our latest analysis for Soleno Therapeutics. That recent momentum sits against a mixed longer record, with a 34.01% 1 month share price return and 25.64% 3 month share price return contrasting with a 28.21% 1 year total shareholder return decline but a very large 3 year total...
NYSE:CAG
NYSE:CAGFood

Is There Now An Opportunity In Conagra Brands (CAG) After Prolonged Share Price Weakness

If you are wondering whether Conagra Brands at around US$14 still reflects the underlying business, the current share price alone does not tell the full story. The stock has seen a 1.9% decline over the last week, a 10.9% decline over the last month, and is down 19.1% year to date and 34.9% over the last year, which will naturally raise questions about how the market is assessing its risks and potential. These weaker recent returns sit against a longer backdrop, with the stock down 55.6%...
NasdaqGS:GT
NasdaqGS:GTAuto Components

How Investors May Respond To Goodyear (GT) Expanding Premium Tires And Brand Campaigns Before Q1 2026 Results

In recent weeks, Goodyear Tire & Rubber has rolled out multiple initiatives, including the launch of its Vector All Season 4 tire, new Eagle performance marketing campaigns, expanded Goodyear Farm Tire-branded product lines, and a 25% USAA member discount, ahead of reporting Q1 2026 results after market close on May 6, 2026. These launches and partnerships highlight Goodyear’s push into premium and specialized segments while using targeted promotions and brand-building to support its broader...
NYSE:HRB
NYSE:HRBConsumer Services

H&R Block Extends 60 Year Dividend Streak As Yield Rises After Pullback

H&R Block (NYSE:HRB) has declared a quarterly cash dividend, extending a streak of over sixty consecutive years of dividend payments. The dividend reflects a 110% dividend growth since 2016, underlining the company’s long-running focus on shareholder returns. This decision follows a period of substantial capital returns via both dividends and share repurchases. H&R Block, trading at $30.02, has a long history of returning cash to shareholders through dividends, and the latest declaration...
NasdaqGS:SEIC
NasdaqGS:SEICCapital Markets

A Look At SEI Investments (SEIC) Valuation After The Expanded Carlyle Private Markets Partnership

Why the Carlyle partnership matters for SEI Investments (SEIC) The expanded partnership between SEI Investments (SEIC) and Carlyle centers on giving wealth and retirement clients greater access to institutional-style private market strategies, including new model portfolios and defined contribution focused solutions. See our latest analysis for SEI Investments. SEI Investments’ latest share price of $90.79 comes after a 17.89% 1 month share price return and a 9.37% year to date gain, while...
NYSE:PB
NYSE:PBBanks

Surging Credit Costs and Steady Payouts Could Be A Game Changer For Prosperity Bancshares (PB)

In the first quarter of 2026, Prosperity Bancshares reported net interest income of US$321.15 million and net income of US$116.27 million, while net charge-offs rose to US$41.31 million from US$2.70 million a year earlier. Alongside higher credit costs, the bank continued capital returns through share repurchases and maintained its quarterly dividend, signaling ongoing balance-sheet management priorities. Next, we’ll examine how the surge in net charge-offs and related credit costs may...
NasdaqGS:WGS
NasdaqGS:WGSHealthcare

GeneDx Holdings (WGS) Returns To US$17.7 Million Quarterly Loss Challenging Bullish Profitability Narrative

GeneDx Holdings (WGS) opened Q1 2026 with recent quarterly revenue of US$120.99 million in Q4 2025 and a basic EPS loss of US$0.61, alongside trailing 12 month revenue of US$427.54 million and a basic EPS loss of US$0.73. Over the last year, revenue has moved from US$95.64 million in Q4 2024 to US$120.99 million in Q4 2025, while quarterly EPS has swung between a profit of US$0.38 in Q2 2025 and losses of up to US$0.61. This sets up an earnings story that investors may review in terms of how...
NasdaqGS:VECO
NasdaqGS:VECOSemiconductor

What Veeco Instruments (VECO)'s Q1 Loss and US$250 Million AI Laser Orders Mean For Shareholders

Veeco Instruments Inc. reported first-quarter 2026 results with sales of US$158.34 million, down from US$167.29 million a year earlier, and swung from an US$11.95 million net profit to a US$0.324 million net loss. At the same time, Veeco announced over US$250 million in new orders for systems used in Indium Phosphide laser manufacturing, underlining growing demand from silicon photonics and hyperscale data centers. We’ll now examine how Veeco’s new US$250 million Indium Phosphide laser...
NasdaqGS:DRH
NasdaqGS:DRHHotel and Resort REITs

Evaluating DiamondRock Hospitality (DRH) Valuation After Strong Q1 Beat And Higher 2026 Guidance

DiamondRock Hospitality (DRH) is back in focus after first quarter 2026 results topped analyst expectations, with management lifting full year revenue and EBITDA guidance and increasing its emphasis on hotel sales and share repurchases. See our latest analysis for DiamondRock Hospitality. The stock has gained clear momentum around these updates, with a 13.07% 1 month share price return and 16.67% year to date share price return, alongside a 49.70% 1 year total shareholder return. This...
NYSE:BLDR
NYSE:BLDRBuilding

Why Builders FirstSource (BLDR) Is Down 15.4% After Posting a Q1 Loss and Launching a $500 Million Buyback Plan – And What's Next

In late April 2026, Builders FirstSource reported first-quarter results showing sales of US$3,287.08 million, a net loss of US$47.41 million, and issued full-year 2026 net sales guidance of US$14.60 billion to US$15.60 billion while launching a new US$500 million share repurchase authorization and continuing to signal interest in acquisitions. Management highlighted an ongoing focus on using free cash flow to fund value-added acquisitions and buybacks even as weaker quarterly performance...
NasdaqGM:ASST
NasdaqGM:ASSTMedical Equipment

Assessing Strive Asset Management (ASST) Valuation After A Sharp One Month Share Price Gain

Event context and recent performance snapshot Strive Asset Management (ASST) stock has drawn attention after recent trading, with a 0.9% one day gain, an 8.0% move over the past week, and a 69.3% rise over the past month. See our latest analysis for Strive Asset Management. At a share price of $16.51, Strive Asset Management has a 30-day share price return of 69.33% and a year-to-date share price return of a 4.52% decline, suggesting recent momentum after earlier weakness. If this kind of...
NYSE:AMPX
NYSE:AMPXElectrical

Is It Too Late To Consider Amprius Technologies (AMPX) After Its Rapid Share Price Surge?

Wondering whether Amprius Technologies at US$21.40 is still worth your attention after a rapid run up, or if the price has already moved ahead of the fundamentals? The stock has returned 8.7% over the last week, 33.8% over the last month, 144.9% year to date, and a very large 1 year return of 822.4%, which puts recent trading firmly on most investors' radar. Recent coverage has focused on Amprius Technologies as interest in battery and electrification related companies has increased, with...
NasdaqGS:FBNC
NasdaqGS:FBNCBanks

Did Stronger Q1 Earnings and New Directors Just Shift First Bancorp's (FBNC) Investment Narrative?

First Bancorp recently reported first-quarter 2026 results, with net interest income rising to US$107.12 million and net income to US$46.66 million, while also disclosing US$1.40 million in net charge-offs for the period. The bank also strengthened its governance and industry expertise by adding alternative-investments specialist Kate Nevin and higher-education leader Peter Hans to its Board of Directors. With earnings growth and expanded board expertise in focus, we’ll now examine how these...
NYSE:ITGR
NYSE:ITGRMedical Equipment

Integer Holdings Review Tests Shareholder Value As Profitability Improves

Integer Holdings (NYSE:ITGR) has begun a comprehensive review of its business and capital structure. The Board is assessing options that may include a sale, merger, or other business combination. The review follows heightened external interest in the company and involves financial and legal advisors. The process is focused on assessing ways to maximize value for existing shareholders. Integer Holdings, traded on the NYSE under the ticker ITGR, operates in the medical technology space,...
NYSE:TROX
NYSE:TROXChemicals

Does Tronox (TROX) Dividend Stability Clash With Truist’s Cost Concerns And Earnings Outlook?

Tronox Holdings plc recently confirmed a quarterly dividend of US$0.0500 per share payable on July 8, 2026, with both the ex-dividend and record dates set in the past on May 11, 2026. Around the same time, Truist downgraded Tronox to Sell, highlighting concerns about cost pressures and near-term earnings guidance despite the dividend affirmation. With Truist’s downgrade foregrounding near-term earnings pressures, we’ll now examine how this development reshapes Tronox’s existing investment...
NasdaqGS:HTLD
NasdaqGS:HTLDTransportation

Does Heartland Express’ (HTLD) Smaller Loss and Leadership Shift Reframe Its Post-Acquisition Integration Story?

Heartland Express, Inc. previously reported first-quarter 2026 results showing sales of US$176.26 million versus US$219.42 million a year earlier, with net loss narrowing to US$4.82 million and no share repurchases during the period under its existing buyback programs. Alongside the smaller loss, investors also learned that long-time executive David P. Millis retired as President of Millis Transfer while remaining on Heartland’s board, a leadership shift that may influence how integration...